PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Jiangsu Tasly Diyi Pharmaceuticals Co., Ltd.

USPTO PatentsView assignee record - 12 granted patents across 7 technology areas, recorded in grant years 2017–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Jiangsu ranks #22,832 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 7 technology areas.

#22,832
of 49,997 US assignees by volume
22nd percentile
by Innovation Score (27.0/100)
13.1
avg claims per patent
-29%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22832 · Foreign Corporation #22,832 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-MICRO 12 grants
  • MID-PACK #22,832/49,997
  • PHOTO-FINISH Jdrf Electromag…
  • CPC-NARROW A61P · 7 areas
  • INNOV-THIN 27.0/100
  • CLAIMS-RICH 13.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DOWN -29% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Jdrf Electromag Engineering Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Jiangsu’s 27.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Jiangsu

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Jiangsu's Innovation Score is 27.0/100 (22nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Jiangsu?

Each dot is one of Jiangsu’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Jiangsu’s own 13.1 claims/patent is ABOVE the 12.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Jiangsu vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 11.911.91212.1 5101520253035 Granted patents (volume) Avg claims / patent Jdrf Electromag Engineering Inc. - 12, 14.75Jdrf Electromag E…JFE Mineral Company, Ltd. - 12, 9.83JFE MineralJiangsu Changjiang Electronics Technology Co., Ltd. - 12, 12.17Jiangsu Changjian…Jiangsu Rotam Chemistry Co., Ltd - 12, 19.08Jiangsu Rotam Che…Jiao Hsiung Industry Corp. - 12, 11.83Jiao Hsiung Indus…Jilin Asymchem Laboratories Co., Ltd. - 12, 10.83Jilin Asymchem La…Jingdong Technology Holding Co., Ltd. - 12, 14.58Jingdong Technolo…JMP Statistical Discovery LLC - 12, 30JMP Statistical D…Jiangsu Tasly Diyi Pharmaceuticals Co., Ltd. - 12, 13.08Jiangsu Tasly Diy…
Jiangsu vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Jiangsu's grants concentrate

Jiangsu Tasly Diyi Pharmaceuticals Co., Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 91.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (3 grants) versus a trough of 1 in 2017. By volume, Jiangsu sits between Jdrf Electromag Engineering Inc. and JMP Statistical Discovery LLC.

Jiangsu's three-year grant acceleration

Jiangsu Tasly Diyi Pharmaceuticals Co., Ltd. shows 1 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Jiangsu's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Jiangsu holds 12 patents at rank #22,821, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Jiangsu

By rank, the assignees closest to #22,821 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Jiangsu's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Jiangsu, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Jiangsu ranks #1,740 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (27 here).

Polder Products, LLC 27 Homemation, Inc. 27 Guangzhou Pulisi Technology Co., Ltd. 27 Shanghai Research Center FOR Wireless Communications 27

Jiangsu's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 22nd percentile higher than 22% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 201720182019202020212022 1
USPTO utility patent grants by year · 2017–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Jiangsu Tasly Diyi Pharmaceuticals Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 8.3%
2018 3 25.0%
2019 3 25.0%
2020 1 8.3%
2021 3 25.0%
2022 1 8.3%

Which technologies does Jiangsu Tasly Diyi Pharmaceuticals Co., Ltd. patent most?

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Jiangsu Tasly Diyi Pharmaceuticals Co., Ltd.'s patent record in context - here's where to go next.

  • Jiangsu Tasly Diyi Pharmaceuticals Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 91.7% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #22,832 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Jiangsu Tasly Diyi Pharmaceuticals Co., Ltd. against Jdrf Electromag Engineering Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 27.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.